Small cell carcinoma presenting as ocular paraneoplastic syndrome due to CRMP-5

References

1. ↵
   1. Bussat A

   (2018) Paraneoplastic syndromes in Ophthalmology. J Fr Ophtalmol 41, e181–e185.
2. ↵
   1. Sheorajpanday R,
   2. Slabbynck H,
   3. Van De Sompel W,
   4. Galdermans D,
   5. Neetens I,
   6. De Deyn PP

   (2006) Small Cell Lung Carcinoma Presenting as Collapsin Response-Mediating Protein (CRMP)-5 Paraneoplastic Optic Neuropathy. J Neuroophthalmol 26, 168–172.
3. ↵
   1. Saito M,
   2. Saito W,
   3. Kanda A,
   4. Ohguro H,
   5. Ishida S

   (2014) A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase. BMC Ophthalmology 14, 5.
4. ↵
   1. Gordon LK

   (2015) Paraneoplastic Syndromes in Neuro-Ophthalmology. J Neuroophthalmol 35, 306–314.
5. ↵
   1. Caswell EJ

   (2016) Clinical and Histological Features of Small Cell Lung Cancer Paraneoplastic Inflammatory Uveitis. Ocul Immunol Inflamm 24, 503–507.
6. ↵
   1. Cross SA,
   2. Salomao DR,
   3. Parisi JE,
   4. Kryzer TJ,
   5. Bradley EA,
   6. Mines JA,
   7. et al.

   (2003) Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54, 38–50.
7. ↵
   1. Rahimy E,
   2. Sarraf D

   (2013) Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol 58, 430–458.
8. ↵
   1. Margolin E,
   2. Flint A,
   3. Trobe JD

   (2008) High-Titer Collapsin Response-Mediating Protein-Associated (CRMP-5) Paraneoplastic Optic Neuropathy and Vitritis as the Only Clinical Manifestations in a Patient With Small Cell Lung Carcinoma. J Neuroophthalmol 28, 17–22.
9. ↵
   1. Igarashi N,
   2. Sawamura H,
   3. Kaburaki T,
   4. Aihara M

   (2016) Anti-Collapsing Response-Mediated protein-5 Antibody-Positive Paraneoplastic Perioptic Neuritis without Typical Neurological Symptoms. Neuroophthalmology 41, 24–29.